Top Genen­tech re­searcher steps away and Roche turns to the Broad for a star re­place­ment play­er

Michael Var­ney is step­ping away from his top post in Genen­tech R&D, and the sto­ried biotech is pluck­ing a star cell ex­pert from the Broad as his re­place­ment.

Aviv Regev will now be tak­ing a lead­ing role in a $10 bil­lion re­search or­ga­ni­za­tion as head of Genen­tech Re­search and Ear­ly De­vel­op­ment, bet­ter known as gRED to Basel-based pRED, and join­ing the ex­ec­u­tive com­mit­tee at Roche. Af­ter pick­ing up her PhD at Tel Aviv Uni­ver­si­ty in com­pu­ta­tion­al bi­ol­o­gy, Regev went on to be­come a top in­ves­ti­ga­tor in bi­o­log­i­cal net­works, gene reg­u­la­tion and evo­lu­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER